December 22, 2022 BillionToOne secures additional $83.5M to accelerate growth and commercialize its Northstar Select and Northstar Response liquid biopsy tests in early 2023→ December 22, 2022/ Jack Liang BillionToOne Secures $83.5M in Private Funding, Loan Facility; Shows Clinical Performance of NIPTRead More —>
